These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8025209)

  • 41. The regulation of autoimmunity through CD4+ T cells.
    Hutchings P; Parish N; O'Reilly L; Dawe K; Roitt IM; Cooke A
    Autoimmunity; 1993; 15 Suppl():21-3. PubMed ID: 8105991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C
    Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.
    Buschard K; Pedersen C; Hansen SV; Hageman I; Aaen K; Bendtzen K
    Autoimmunity; 1992; 14(2):101-4. PubMed ID: 1303676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.
    Tisch R; Wang B; Weaver DJ; Liu B; Bui T; Arthos J; Serreze DV
    J Immunol; 2001 Feb; 166(3):2122-32. PubMed ID: 11160264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.
    Staeva TP; Chatenoud L; Insel R; Atkinson MA
    Diabetes; 2013 Jan; 62(1):9-17. PubMed ID: 23258904
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 48. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats.
    Zipris D; Greiner DL; Malkani S; Whalen B; Mordes JP; Rossini AA
    J Immunol; 1996 Feb; 156(3):1315-21. PubMed ID: 8558012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
    Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
    J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclophosphamide inhibits the development of diabetes in the diabetes-prone BB rat.
    Sobel DO; Ahvazi B; Jun HS; Chung YH; Yoon JW
    Diabetologia; 2000 Aug; 43(8):986-94. PubMed ID: 10990075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes.
    Song A; Winer S; Tsui H; Sampson A; Pasceri P; Ellis J; Elliott JF; Dosch HM
    Eur J Immunol; 2003 Feb; 33(2):546-55. PubMed ID: 12645954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunology of insulin-dependent diabetes mellitus.
    Rossini AA; Mordes JP; Like AA
    Annu Rev Immunol; 1985; 3():289-320. PubMed ID: 3904771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene therapy in diabetes mellitus: promises and piffalls.
    Welsh N
    Curr Opin Mol Ther; 1999 Aug; 1(4):464-70. PubMed ID: 11713761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune cells, pancreas development, regeneration and type 1 diabetes.
    Homo-Delarche F; Drexhage HA
    Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune modulation for prevention of type 1 diabetes mellitus.
    Raz I; Eldor R; Naparstek Y
    Trends Biotechnol; 2005 Mar; 23(3):128-34. PubMed ID: 15734555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isohormonal therapy of endocrine autoimmunity.
    Schloot N; Eisenbarth GS
    Immunol Today; 1995 Jun; 16(6):289-94. PubMed ID: 7662098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
    LaFace DM; Peck AB
    Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.